- Telehealth Visits
- Insurance plan information
Kate Swanson, MD
She | Her | HersObstetrics and Gynecology- Telehealth Visits
- Insurance plan information
Kate Swanson, MD
She | Her | HersObstetrics and Gynecology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Kate Swanson is a perinatologist who cares for people with complex pregnancies, particularly those related to maternal or fetal genetic conditions. She also provides preconception care to families at risk of pregnancy complications or with a history of pregnancy loss.
In her research, Swanson focuses on the use of prenatal genetic testing to support patients, including how to make it accurate, accessible and understandable.
Swanson earned her medical degree and completed a residency in obstetrics and gynecology at Northwestern University. She completed a fellowship in maternal-fetal medicine and medical genetics at UCSF.
Education & training
Board certification
- Maternal-Fetal Medicine, American Board of Obstetrics and Gynecology
- Clinical Genetics and Genomics, American Board of Medical Genetics and Genomics
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Maternal and Fetal Medicine, UCSF Graduate Medical Education
Residency
- Medical Genetics, UCSF Graduate Medical Education
- Obstetrics & Gynecology, McGaw Medical Center of Northwestern University
Degree
- MD, Northwestern University Feinberg School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223081%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223081%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.